Value-Based Healthcare – Can We Afford A Cure ?

Mr. Omar Ali

ucjournals October 1, 2024

153 2 minutes read

Speaker Name: Mr. Omar Ali
She will present her oral presentation at the 14th International Healthcare, Hospital Management, Nursing, and Patient Safety Conference from July 25-28, 2024 in Holiday Inn Dubai, UAE & Virtual.
Category: Speaker
Global Journal of Healthcare, Hospital Management, Nursing, and Patient Safety Unified Citation Journals, Nursing 2024, ISSN 2754-0952
Affiliation: University Portsmouth UK

Abstract:

Introduction: With rising healthcare costs and post-pandemic global shrinking economies, the value of healthcare delivery and accountability to delivering patient outcomes has never been more critical. With increasingly innovative medicines in cancer, rare disease and curative gene therapies, multi-million dollar drugs are beginning to test sustainability of healthcare systems and government payers. With patient demands for new medicines ever increasing, this presentation evaluates value based healthcare, innova-tive contracts and reimbursement of drugs based on their outcomes, In essence, if the medicines doesn’t work; then we wont pay for it! We will cover exemplar cases, global trends and critically how to overcome barriers to successful deploy-ment of these contracts between pharmaceutical companies and government & commercial payers around the globe.

Keywords: value based healthcare, innovative contract-ing.

Digital Formats: Presented at American Managed Care Pharmacy Annual Conference April 2024

Biography:

Omar Ali has undertaken his PhD from University of Ports-mouth in the UK. He has over 25 years of hospital speciality pharmacy & management experience and also served as a government adviser on NICE HTA for 10 years. His PHD covers value based healthcare and innovative contracting with new medicines and health technologies. He has pub-lished more than 20 papers in different journals and is a sea-soned presenter around the globe.

References:

[1] Ali O., Kefalas P. Establishing the cost of implementing a performance based managed entry agreement for CAR-T therapy (2018) Vol6, 1511679 Journal of Market Access & Health Policy.

Tags:

Healthcare, Nursing & Health Sciences, Healthcare Simulation, Home Care Nursing Services, Advanced Healthcare, Types of Nursing in Healthcare, Public Health Nursing, Healthcare Leadership, Healthcare Management, Hospital Management, Internal Medicine, Pharmacology, Psychiatry and Mental Health, Healthcare Quality, Family Medicine, Child Health Advanced Nursing Practices during Pandemic, Nurse Protection during Pandemics, Oncology Nursing, Cardiac Nursing, Gynacology and Obstetrics Nursing, Nursing Education, Global Healthcare, Family Nursing, Men in Nursing, Nursing Care, Women Health Nursing, Infection Control, Healthcare Quality improvement, Tele Healthcare, Digital Healthcare, Healthcare Services, Healthcare Marketing